Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-24 @ 7:52 PM
NCT ID:
NCT01788904
Eligibility Criteria:
Inclusion Criteria:
* Presence of acute mesenteric ischemia due to stenosis of the superior mesenteric artery, thromboembolization of the superior mesenteric artery, non-occlusive mesenteric ischemia or acute portal vein thrombosis (as confirmed by CT scan)
* The vascular anatomy is suitable for percutaneous revascularization
* A primary endovascular re-vascularisation approach is intended based on an interdisciplinary decision by the visceral surgeon, the vascular surgeon and interventional radiologist. This therapeutic decision is made independently of the proposed FARAMIS study.
* A peripheral or central line is present to perform repeated blood collections
Exclusion Criteria:
* Clinically or imaging results indicating that perforation of the bowel is present or suspected
* Hemodynamic instability (shock)
* Pre-existing severe liver or kidney damage (defined as spontaneous international normalized ratio \>2 or creatinine \>2 mg/dl.)
* Anemia with hemoglobin concentration \< 7g/dl
* Pediatric patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01788904
Study Brief:
Protocol Section:
NCT01788904